Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Leukapheresis for CAR T- Cell Manufacturing

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Leukapheresis for CAR T- Cell Manufacturing
Conditions:   Solid Tumor, Adult;   Colorectal Cancer;   Non Small Cell Lung Cancer;   Pancreatic Cancer;   CRC;   NSCLC;   Pancreas Cancer
Interventions:   Other: Leukapheresis;   Diagnostic Test: Next Generation Sequencing (NGS);   Diagnostic Test: Long Range NGS HLA typing
Sponsors:   A2 Biotherapeutics Inc.;   Tempus Labs
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 30, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments